Home/Atomic AI/Raphael Townshend

RT

Raphael Townshend

Founder & CEO

Therapeutic Areas

Oncology Genetic Diseases Neurological Disorders Infectious Diseases

Atomic AI Pipeline

Drug	Indication	Phase
Undisclosed RNA-targeted small molecule programs	Targeting traditionally undruggable RNA targets across multiple disease areas	Discovery

Leadership Team at Atomic AI

Stephan Eismann

Founding Scientist, Head of Machine Learning

Brent Townshend

Head of ML Data Generation

View full Atomic AI profile